SAT399 Are Gender-affirming Hormone Therapy Duration And Body Mass Index Associated With Bone Mineral Density In Transgender And Gender Diverse Adults?

Disclosure: S.J. Iwamoto: None. J.D. Rice: None. N.J. Nokoff: None. K.L. Moreau: None. M. Cornier: None. M.E. Wierman: None. M.P. Mancuso: None. M.S. Rothman: None. Background: Sex steroids play crucial roles in bone mineral density (BMD) accrual and maintenance. Data on gender-affirming hormone the...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwamoto, Sean J, Rice, John D, Nokoff, Natalie J, Moreau, Kerrie L, Cornier, Marc-Andre, Wierman, Margaret E, Mancuso, Mary P, Rothman, Micol S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Transgender Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554757/
http://dx.doi.org/10.1210/jendso/bvad114.2070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554757/
http://dx.doi.org/10.1210/jendso/bvad114.2070

Ejemplares similares